biote Corp. (BTMD)

Listed in the US · Manufacturing · Medicinal chemicals and botanical products

$1.17

As of 29 Oct 2026 close.

Facts from reported results and exchange filings. Not investment advice.

Share price

Prices load here as you scroll to them.

Last close $1.17 on 29 Oct 2026. The share price traded between $1.00 and $2.98 (intraday) over the last 12 months.

The closes as a table

DateClose

Key figures

1-year range (intraday)

Last close $1.17

Low $1.00High $2.98

Market cap$42Mlast close × shares
P/E10.6on reported profit, last four quarters
Net profit$5.86Mlast 12 months
EBITDA margin20.4%year to Dec 2025
Net margin14.1%year to Dec 2025

Price trend

Revenue and profit

RevenueNet profit$ million
-50050100150200
YearDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue139165185197192
Net profit11-13327
EBITDA margin25.8%-35.5%17.1%17.8%20.4%
Borrowings37122116109103

$ million. Over three years, compounded: revenue grew 5.2% a year.

Recent filings

Questions about biote Corp.

What is biote Corp.'s market value?

biote Corp.'s market value is $42M as of 29 Oct 2026 close: the last close times the shares in issue. Its P/E is 10.6, the last close over earnings per share for the last four reported quarters.

When are biote Corp.'s next results?

biote Corp.'s next results are listed for 4 Nov 2026 (the exchange's notice: Quarterly results (quarter ended Sep 2026)). Dates are as the company announced them, on the list of 30 Oct 2026.

Go further with BTMD

Free to start: test a trading idea on BTMD's real prices after costs, or open the full deep dive with ten years of numbers, red flags and management's record.

Same industry

The largest companies in the same industry (Medicinal chemicals and botanical products), by market value.

Browse companies

The companies before and after this one, A to Z, and the lists it is in.

How these figures are worked out

The net profit for the last 12 months is the four latest reported quarters, so it can differ from the newest year's in the table below.